Gene Therapy
Research from University of Barcelona, Cardiovascular Research Center in the area of gene therapy published
Published in Cardiovascular Device Liability Week, July 15th, 2007
Researchers detail in "Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages," new data in gene therapy. According to a study from Spain, "In the extracellular intima, extracellular matrix proteoglycans favor LDL retention and aggregation (agLDL). In contrast to native LDL (nLDL), agLDL induces high intracellular cholesteryl ester (CE) accumulation in macrophages."
"It has been suggested that LDL receptor-related protein (LRP1) is involved in agLDL binding and internalization by macrophages. The aim of this work was to analyze whether sterol regulatory element...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Abdominal Aortic Aneurysm
Reports from Tokyo Women's Medical University, Department of Cardiology describe recent advances in abdominal aortic aneurysm - Abdominal Aortic Aneurysm Epidemiology
Data from Uppsala University, Department of Surgical Sciences provide new insights into abdominal aortic aneurysm epidemiology - Abdominal Aortic Aneurysm Epidemiology
Researchers from University of Missouri, Division of Vascular Surgery report details of new studies and findings in the area of abdominal aortic aneurysm epidemiology - Abdominal Aortic Aneurysm Risk Factors
Recent studies from University of Texas, Department of Surgery add new data to abdominal aortic aneurysm risk factors - Abdominal Aortic Aneurysm Risk Factors
Studies from Scientific Institute in the area of abdominal aortic aneurysm risk factors published - Adverse Drug Reactions
Research data from University of Kentucky, Department of Surgery update understanding of adverse drug reactions - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
